Alembic Pharmaceuticals informs about company updates

15 May 2017 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (FDA) approval for Fenofibric Acid Delayed-Release Capsules.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

937.00 -9.30 (-0.98%)
28-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.